Modulation of Gene Expression in Human Breast Cancer MCF7 and Prostate Cancer PC3 Cells by the Human Copper-Binding Peptide GHK-Cu
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index; 10 of the 47 sources its claims cite were checked for support.
Abstract
The human copper-binding peptide GHK-Cu is a naturally occurring small plasma tripeptide (glycyl-l-histidyl-l-lysine) with a high affinity for copper (2+). GHK-Cu has multiple biological effects. It is known to stimulate regeneration of skin, nervous tissue, bones, lungs and liver, protect liver from oxidative damage, restore activity of irradiated fibroblasts, reduce inflammation and increase levels of antioxidant enzymes. Recent studies established that GHK modulates activity of a number of genes. It has been shown to reverse pathological expression of 70% genes in a gene signature for metastasis-prone colon cancer and shift gene expression in COPD lungs from destruction to healthy remodeling. In this paper, we present GHK-Cu’s gene effects on MCF7 breast cancer cells and PC3 prostate cancer cells and review laboratory evidence supporting GHK’s ability to restore tissue integrity and health via multiple mechanisms, which can be beneficial for cancer treatment.
Overview
CoChat Summary
## TL;DR
The paper uses gene-profiling data from the Broad Institute Connectivity Map to examine how the human copper-binding peptide GHK-Cu affects gene expression in MCF7 breast cancer cells and PC3 prostate cancer cells. It reports that GHK upregulates several apoptosis and tumor-suppressor genes and downregulates genes associated with cancer progression and drug resistance, and argues this supports further study of GHK-Cu in cancer therapy.
## Key findings
- GHK upregulated caspase genes involved in apoptosis, including CASP1 (272% in MCF7; 173% in PC3), CASP3 (19%; 79%), CASP6 (62%; 21%), CASP7 (93%; 10%), CASP8 (NS; 501%), and CASP10 (1781%; 195%).
- The paper reports strong upregulation of several tumor-suppressor/growth-inhibitory genes, including USP29 (1749% in MCF7; 687% in PC3), IFNA21 (5336%; 507%), TP73 (1634%; 283%), LEFTY2 (1961%; 620%), and IL25 (690%; 1040%).
- ATM is highlighted as especially important, and the paper states that GHK stimulates ATM RNA production by 80% in breast cancer cells and 120% in prostate cells.
- GHK downregulated genes associated with cancer progression/drug resistance, including ABCB1 (-900% in MCF7; -2451% in PC3), STAT5A (-4077%; -359%), IGF1 (NS; -864%), FGFR2 (-243%; -235%), FAIM2 (-590%; -462%), and TNF (124%; -153%).
## Methods
- The study used two approaches to assess GHK effects on gene expression: Gene Ontology-based analysis and a manual search of all genes affected by GHK.
- It analyzed public data from the Broad Institute Connectivity Map (CMap), using GHK profiles from PC3 human prostate cancer cells and MCF7 human breast cancer cells.
- Data were processed in GenePattern; CEL files were handled with MAS5 and background correction, then viewed in ComparativeMarkerSelectionViewer and reported as fold-changes converted into percentage changes. The paper also compared GHK to other compounds using the Broad Institute Chembank.
## Limitations
- The authors state that the Gene Ontology approach is limited because it does not cover all human cancers; they note there are over 100 human cancers and not all are represented.
- The paper itself says that gene data alone would not be enough to conclude GHK should become an anti-cancer therapeutic, so the interpretation is suggestive rather than definitive.
- Evident from the text: this is a computational / database-based analysis of cell-line profiles, so it does not report direct experiments measuring cancer outcomes in patients.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
10 Valid · 3 Not valid · 31 Not checked · 35 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In this study, it was confirmed that the Broad Institute Connectivity Map is a reliable tool allowing prediction of biological actions of various compounds.”
§ Modulation of Gene Expression in Human Breast Cancer MCF7 and Prostate Cancer PC3 Cells by the Human Copper-Binding Peptide GHK-Cu > 1. Introduction
What the sources say
- Partly supportedcites [4] Meiners S, Eickelberg O. Next-generation personalized drug discovery: The tripeptide GHK hits center stage in chronic obstructive pulmonary disease. Genome Med. 2012; 4: 70. sourceExperimental — accuracy not yet measured
The ‘Unbiased identification of new drugs’ section describes CMap as a screening tool that connects compounds with potential biological effects, and ‘Future directions’ says studies have shown its feasibility for identifying therapeutics and predicting side effects. The paper does not establish that its predictions are generally reliable; the GHK result described there was only partially validated in vitro. (LLM, conf=0.82)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“It was confirmed that beneficial gene effects of GHK, discovered through the computer-based tool The Connectivity Map, correlate with its effects in vitro.”
§ Modulation of Gene Expression in Human Breast Cancer MCF7 and Prostate Cancer PC3 Cells by the Human Copper-Binding Peptide GHK-Cu > 1. Introduction
What the sources say
- Supportedcites [4] Meiners S, Eickelberg O. Next-generation personalized drug discovery: The tripeptide GHK hits center stage in chronic obstructive pulmonary disease. Genome Med. 2012; 4: 70. source
The “Unbiased identification of new drugs” section says CMap identified GHK through its inverse connectivity with emphysema-related gene-expression changes. It also reports that GHK partially reversed emphysema-associated phenotypes in fibroblasts from COPD patients, supporting the claimed correspondence with in vitro effects. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In early wound healing experiments, GHK was found to stimulate production of a small, leucinerich proteoglycan, decorin.”
§ Modulation of Gene Expression in Human Breast Cancer MCF7 and Prostate Cancer PC3 Cells by the Human Copper-Binding Peptide GHK-Cu > 3.2 Biological Effects of GHK-Cu Which Support Its Beneficial Effects on Tissue Integrity and Health
What the sources say
- Supportedcites [36] Siméon A, Wegrowski Y, Bontemps Y, Maquart FX. Expression of glycosaminoglycans and small proteoglycans in wounds: Modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. J Invest Dermatol. 2000; 115: 962-968. source
The results section reports that GHK-Cu increased decorin expression in rat wound chambers and that immunoprecipitation confirmed increased decorin production by cultured rat dermal fibroblasts. The cited experiments used the copper complex GHK-Cu. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“GHK upregulates expression of caspases, such as CASP1, 3, 6,7 8 and 10 (Table 1).”
§ Modulation of Gene Expression in Human Breast Cancer MCF7 and Prostate Cancer PC3 Cells by the Human Copper-Binding Peptide GHK-Cu > 3.1 The Gene Expression Data
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“GHK and gene expression in cancer suppressors in MCF7 and PC3 cells.”
§ Modulation of Gene Expression in Human Breast Cancer MCF7 and Prostate Cancer PC3 Cells by the Human Copper-Binding Peptide GHK-Cu > 4. Conclusion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
22 more claims
Create a free account to see all 79 claims and to verify the 6 references still open.
- Probably not a substantial claim. 20
- It may state two separate claims as one. 37
- Borderline: one of the tests for a substantial claim is unclear. 1
- The quote only partly states this claim. 3
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Hong, Y., Downey, T., Eu, K. W., Koh, P. K., & Cheah, P. Y. (2010) · Clinical & Experimental Metastasis · doi:10.1007/s10585-010-9305-4 · Cited by 319
SPARC is a source of copper-binding peptides that stimulate angiogenesis
Lane, T. F., Iruela-Arispe, M. L., Johnson, R. S., & Sage, E. H. (1994) · The Journal of cell biology · doi:10.1083/jcb.125.4.929 · Cited by 249
The human tri-peptide GHK and tissue remodeling
Pickart, L. (2008) · Journal of Biomaterials Science, Polymer Edition · doi:10.1163/156856208784909435 · Cited by 218
Self-citationDecorin prevents metastatic spreading of breast cancer
Reed, C. C., Waterhouse, A., Kirby, S., Kay, P., Owens, R. T., McQuillan, D. J., & Iozzo, R. V. (2005) · Oncogene · doi:10.1038/sj.onc.1208329 · Cited by 209
Maquart, F.-X., Pickart, L., Laurent, M., Gillery, P., Monboisse, J.-C., & Borel, J.-P. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80509-x · Cited by 181
Self-citationGHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration
Pickart, L., Vasquez-Soltero, J. M., & Margolina, A. (2015) · BioMed Research International · doi:10.1155/2015/648108 · Cited by 144
Self-citationLiu, J., Chung, H., Vogt, M., Jin, Y., Malide, D., He, L., Dundr, M., & Levens, D. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.11 · Cited by 141
Campbell, J. D., McDonough, J. E., Zeskind, J. E., Hackett, T. L., Pechkovsky, D. V., Brandsma, C.-A., Suzuki, M., Gosselink, J. V., Liu, G., Alekseyev, Y. O., et al. (2012) · Genome Medicine · doi:10.1186/gm367 · Cited by 128
Siméon, A., Wegrowski, Y., Bontemps, Y., & Maquart, F.-X. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00166.x · Cited by 119
Research works printed but not linked: 3
- Pickart L, Margolina A. Anti-aging activity of the GHK peptide-the skin and beyond. J Aging Res Clin Pract. 2012; 1: 13-15.
- Cherdakov VY, Smakhtin MY, Dubrovin GM, Dudka VT, Bobyntsev II. Synergetic antioxidant and reparative action of thymogen, dalargin and peptide gly-his-lys in tubular bone fractures. Exp Biol Med. 2010; 4: 15-20.
- Sakuma S, Ishimura M, Yuba Y, Itoh Y, Fujimoto Y. The peptide glycyl-ʟ-histidyl-ʟ-lysine is an endogenous antioxidant in living organisms, possibly by diminishing hydroxyl and peroxyl radicals. Int J Physiol Pathophysiol Pharmacol. 2018; 10: 132.
Cited by
Tosto, R., Vecchio, G., & Bellia, F. (2023) · Molecules · doi:10.3390/molecules28186724 · Cited by 6
Copper Peptides in Regenerative Aesthetic Dermatology
Sarbaziha, R., & Goldberg, D. J. (2026) · Dermatological Reviews · doi:10.1002/der2.70067 · Cited by 4
“Experimental and clinical investigations consistently demonstrate that GHK‐Cu plays a critical role in maintaining skin and connective‐tissue integrity by promoting cellular proliferation, collagen synthesis, and repair‐ related signaling pathways [7–13].”
InfluentialBıçak, B., & Kecel‐Gunduz, S. (2023) · Hittite Journal of Science & Engineering · doi:10.17350/hjse19030000309 · Cited by 2
Metadata
- Authors
- Pickart, L., & Margolina, A.
- Corresponding author
- Margolina, Anna
- Venue
- OBM Genetics
- Publisher
- LIDSEN Publishing Inc
- Published
- 2021-04-06
- Volume
- 05
- Issue
- 02
- Pages
- 1-18
- ISSN
- 2577-5790 (ISSN-L)
- OpenAlex
- W3151687174
- Cited by
- 3
- References
- 41
- Citations by year
- 2026: 1 · 2023: 2
- FWCI
- 0.32
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- OBM Genetics (publishedVersion, cc-by)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Health Sciences › Medicine › Surgery › Wound Healing and Treatments
- Health Sciences › Medicine › Physiology (medical) › Biochemical effects in animals
- Keywords
- GHK-Cu, copper-binding peptides, gene expression modulation, MCF-7 cells, PC-3 cells, breast cancer, prostate cancer, copper, anticancer peptides, tissue regeneration, oxidative stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Modulation of Gene Expression in Human Breast Cancer MCF7 and Prostate Cancer PC3 Cells by the Human Copper-Binding Peptide GHK-Cu. https://app.cochat.ai/papers/10.21926/obm.genet.2102128
- The paper
- Pickart, L., & Margolina, A. (2021). Modulation of Gene Expression in Human Breast Cancer MCF7 and Prostate Cancer PC3 Cells by the Human Copper-Binding Peptide GHK-Cu. OBM Genetics. https://doi.org/10.21926/obm.genet.2102128
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.